Pfizer Inc. (PFE) is a Healthcare company in the Drug Manufacturers - General industry with a 63% Hold Score. Key strengths include Gross Margin (75.8%), Net Margin (12.4%). Areas to watch: Revenue Growth (-1.2%). Our AI evaluates 8 fundamental categories including revenue growth, margin quality, balance sheet strength, cash flow generation, return on capital, and valuation metrics.
See how our AI analyzes PFE fundamentals to generate buy/sell signals and Strong Buy Scores.
Based on our AI-powered fundamental analysis, PFE has a Strong Buy Score of 63%, earning a "Hold" rating. This score synthesizes 8 key financial metrics to provide an objective investment signal.
Pfizer Inc. shows mixed fundamentals with some strengths and areas to monitor. Positives include Gross Margin (75.8%). Watch for Revenue Growth (-1.2%).
Our AI analyzes Pfizer Inc.'s financial statements to generate buy/sell signals based on quantitative metrics, not market sentiment or news headlines. Here's what drives the 63% score:
Generate the full PDF report for complete category-by-category scoring and AI-powered investment recommendations.
Technical traders can view real-time demand and supply zones for PFE on our Demand Zones page. These zones identify key price levels where institutional buying or selling has historically occurred.
With PFE currently trading at $27.09, our system monitors proximity to these critical levels and can alert you when the stock approaches support or resistance zones.
Subscribe to demand zone alerts to receive real-time notifications when PFE reaches key technical levels.
Pfizer Inc. operates in the Healthcare sector, specifically in Drug Manufacturers - General. Understanding earnings trends is crucial for forecasting PFE's trajectory.
Current revenue growth of -1.2% trails the average company.
Visit our Earnings Calendar to track upcoming PFE earnings dates and historical beat/miss patterns. Sign up for earnings alerts to get notified before announcements.
Our AI projects PFE's trajectory based on current fundamentals and historical patterns. With a 63% Strong Buy Score, here's what the data suggests:
Mixed Outlook: Pfizer Inc. shows moderate fundamental strength. Revenue growth at -1.2% and warrants monitoring. The stock may trade sideways or experience modest gains depending on execution and market conditions.
For a complete 12-month price forecast with specific bull/bear scenarios, generate the full PDF report.
Understanding valuation is critical for determining if PFE is fairly priced. Here's the current snapshot:
Our AI weighs these metrics against growth rates and margin quality to determine if PFE offers compelling risk-adjusted returns at current prices.
Here's why investors are bullish on Pfizer Inc.:
While these positives exist, investors should weigh them against the risks outlined in the bear case below.
Every investment carries risk. Here are potential concerns for PFE investors:
The full PDF report includes a detailed bear case analysis with specific risk ratings for each category.
PFE Summary: Pfizer Inc. earns a 63% Hold Score based on AI analysis of fundamental data. Trading at $27.09 with a $154.03B market cap, the stock presents a balanced risk/reward profile for the coming year.
Bull Case: Gross Margin (75.8%), Net Margin (12.4%)
Watch: Revenue Growth (-1.2%)
For the complete analysis with specific price considerations, growth projections, and AI-powered buy/hold/sell recommendations, generate your free PFE PDF report.